Natera, Inc. (NTRA) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Natera (NTRA) Q1 2026: Oncology Volumes Surge 55% as ASP Momentum Unlocks Margin Upside
May 08, 2026
-
Natera (NTRA) Q4 2025: MRD Clinical Units Surge 56%, Expanding Oncology Moat
February 28, 2026
-
Natera (NTRA) Q3 2025: Signatera Volumes Surge 56%, Fueling Guidance Reset and Margin Expansion
November 07, 2025
-
Natera (NTRA) Q2 2025: Signatera Volumes Jump 20,000 Units, Fueling $80M Guidance Raise
August 08, 2025
-
Natera (NTRA) Q1 2025: Signatera Clinical Volumes Jump 52% as ASP Expansion Drives Margin Gains
July 05, 2025